Efonidipine
- Generic Name
- Efonidipine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C34H38N3O7P
- CAS Number
- 111011-63-3
- Unique Ingredient Identifier
- 40ZTP2T37Q
- Background
Efonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to L-type calcium channels . It has also been studied in atherosclerosis and acute renal failure . This drug is also known as NZ-1...
- Indication
用于治疗高血压和心绞痛。
- Associated Conditions
- -
- Associated Therapies
- -
Role of Calcium Channels in Vascular Function
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-08-31
- Last Posted Date
- 2021-06-01
- Lead Sponsor
- University of Southern Denmark
- Target Recruit Count
- 12
- Registration Number
- NCT02885558
- Locations
- 🇩🇰
Centre for Phsical Activity Research, Copenhagen, Denmark
🇩🇰Cardiovascular and Renal Research, Odense, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath